Genetic Epidemiology, Translational Neurogenomics, Psychiatric Genetics and Statistical Genetics Laboratories investigate the pattern of disease in families, particularly identical and non-identical twins, to assess the relative importance of genes and environment in a variety of important health problems.
QIMR Home Page
GenEpi Home Page
About GenEpi
Publications
Contacts
Research
Staff Index
Collaborators
Software Tools
Computing Resources
Studies
Search
GenEpi Intranet
PMID
41807453
TITLE
A large-scale genome-wide association meta-analysis for nevus count provides direct insights into the genetics of melanoma.
ABSTRACT
A greater understanding of the biology of nevi will provide insights into the etiology of melanoma. Our large-scale meta-analysis of 14 nevus genome-wide association studies (GWAS) includes 85,965 individuals of European ancestry. We identify 29 nevus-associated loci (p < 5 × 10 ), of which 24 have not been previously reported in a GWAS conducted for nevus count alone. We further identify 255 candidate genes for nevus loci, including SIKE1 which is involved in immune response regulation. This is of interest because immune response regulation influences the formation of nevi and melanoma susceptibility. Gene-set enrichment analyses prioritise immune response-related pathways and cancers that do not have a pigmentation component (e.g. breast, prostate, and glioma). This suggests that the biology underlying nevus count captures risk pathways beyond pigmentation that are relevant to melanoma. In sex-specific analyses, we observe higher total-body nevus count in females than in males, however the genetic architecture is largely shared (genetic correlation = 0.863, 95% CI = 0.453 - 1.273), indicating the difference may be influenced by environmental and behavioural factors rather than genetics. A nevus polygenic risk score explains 5% of the variance in nevus count, indicating its potential to enhance melanoma risk prediction.
© 2026. The Author(s).
DATE PUBLISHED
2026 Mar 10
HISTORY
PUBSTATUS PUBSTATUSDATE
received 2025/02/20
accepted 2026/02/25
medline 2026/04/24 00:32
pubmed 2026/03/11 06:58
entrez 2026/03/11 00:18
pmc-release 2026/03/10
AUTHORS
NAME COLLECTIVENAME LASTNAME FORENAME INITIALS AFFILIATION AFFILIATIONINFO
Jayasinghe GJMSR Jayasinghe G J M Shanika R GJMSR School of Biomedical Sciences, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD, Australia. shanika.jayasinghe@qimrb.edu.au.
Zhu G Zhu Gu G Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Pandeya N Pandeya Nirmala N School of Public Health, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD, Australia.
Olsen CM Olsen Catherine M CM Dermatology Research Centre, Frazer Institute, The University of Queensland, Brisbane, QLD, Australia.
Martin NG Martin Nicholas G NG Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Lind PA Lind Penelope A PA School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia.
Medland SE Medland Sarah E SE School of Psychology, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD, Australia.
Gordon SD Gordon Scott D SD Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Diaz-Torres S Diaz-Torres Santiago S Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Lingham G Lingham Gareth G Centre for Eye Research Australia, East Melbourne, VIC, Australia.
Lee SSY Lee Samantha S Y SSY Centre for Ophthalmology and Visual Science (incorporating the Lions Eye Institute), The University of Western Australia, Nedlands, WA, Australia.
Nijsten T Nijsten Tamar T Department of Dermatology, Erasmus MC Cancer Institute, Erasmus MC University Medical Centre Rotterdam, Rotterdam, The Netherlands.
Kayser M Kayser Manfred M Department of Pathology and Clinical Bioinformatics, Erasmus MC Cancer Institute, Erasmus MC University Medical Centre Rotterdam, Rotterdam, The Netherlands.
Pardo LM Pardo Luba M LM Department of Dermatology, Erasmus MC Cancer Institute, Erasmus MC University Medical Centre Rotterdam, Rotterdam, The Netherlands.
Montgomery GW Montgomery Grant W GW Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD, Australia.
Hayward NK Hayward Nicholas K NK Oncogenomics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Palmer JM Palmer Jane M JM Oncogenomics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Hunter DJ Hunter David J DJ Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.
Han J Han Jiali J Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, 1050 Wishard Boulevard, Indianapolis, IN, USA.
Hewitt AW Hewitt Alex W AW Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia.
Falchi M Falchi Mario M Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.
Bishop DT Bishop D Timothy DT Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.
Brown KM Brown Kevin M KM Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Bataille V Bataille Veronique V Department of Dermatology, Hemel Hempstead Hospital, West Hertfordshire NHS Trust, Hemel Hempstead, UK.
Mackey DA Mackey David A DA Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC, Australia.
Iles MM Iles Mark M MM NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Whiteman DC Whiteman David C DC Cancer Control Group, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Duffy DL Duffy David L DL Dermatology Research Centre, Frazer Institute, The University of Queensland, Brisbane, QLD, Australia.
MacGregor S MacGregor Stuart S Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Law MH Law Matthew H MH School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia. Matthew.Law@qimrb.edu.au.
INVESTIGATORS
JOURNAL
VOLUME: 17
ISSUE: 1
TITLE: Nature communications
ISOABBREVIATION: Nat Commun
YEAR: 2026
MONTH: Mar
DAY: 10
MEDLINEDATE:
SEASON:
CITEDMEDIUM: Internet
ISSN: 2041-1723
ISSNTYPE: Electronic
MEDLINE JOURNAL
MEDLINETA: Nat Commun
COUNTRY: England
ISSNLINKING: 2041-1723
NLMUNIQUEID: 101528555
PUBLICATION TYPE
PUBLICATIONTYPE TEXT
Journal Article
Meta-Analysis
COMMENTS AND CORRECTIONS
REFTYPE REFSOURCE REFPMID NOTE
UpdateOf medRxiv. 2025 Feb 25:2025.02.25.25322831. doi: 10.1101/2025.02.25.25322831. 41030926
GRANTS
GENERAL NOTE
KEYWORDS
MESH HEADINGS
DESCRIPTORNAME QUALIFIERNAME
Humans
Genome-Wide Association Study
Melanoma pathology
Male pathology
Female pathology
Genetic Predisposition to Disease pathology
Nevus pathology
Skin Neoplasms pathology
Polymorphism, Single Nucleotide pathology
SUPPLEMENTARY MESH
GENE SYMBOLS
CHEMICALS
OTHER ID's